Drug has successfully completed US Food and Drug Administration’s End of Phase 1 data review LONDON, May 1, 2024 /PRNewswire/ — Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.